CHA2DS2-VASc Score Predict No-Reflow Phenomenon in Primary Percutaneous Coronary Intervention in Primary Percutaneous...

Area of Science:

• Cardiology
• Interventional Cardiology
• Clinical Risk Stratification

Background:

• No-reflow is a significant complication of primary percutaneous coronary intervention (PCI) in acute ST-elevation myocardial infarction (STEMI).
• This phenomenon is linked to adverse clinical outcomes in STEMI patients.
• Existing risk stratification tools may not adequately predict no-reflow post-PCI.

Purpose of the Study:

• To evaluate the effectiveness of the CHA2DS2-VASc score in predicting the no-reflow phenomenon in STEMI patients undergoing primary PCI.
• To determine if the CHA2DS2-VASc score can serve as an independent predictor of no-reflow.
• To establish a potential cutoff value for the CHA2DS2-VASc score for no-reflow prediction.

Main Methods:

• A study involving 396 patients with STEMI who underwent primary PCI.
• Patients were categorized into control (no-reflow) and no-reflow groups based on post-PCI TIMI flow.
• CHA2DS2-VASc scores were calculated, and multivariate regression analysis was employed.

Main Results:

• The CHA2DS2-VASc score independently predicted no-reflow (OR: 3.06, P < 0.001).
• Other predictors included lower systolic blood pressure, higher diastolic blood pressure, initial TIMI flow grade 0, and smaller stent size.
• A CHA2DS2-VASc cutoff score of ≥ 2 demonstrated 88% sensitivity and 67% specificity (AUC: 0.83).

Conclusions:

• The CHA2DS2-VASc score is a valuable and simple tool for predicting no-reflow before primary PCI in STEMI patients.
• Utilizing this score can aid in identifying high-risk individuals and potentially guiding peri-procedural management.
• Further research may explore integrating this score into clinical decision-making algorithms for STEMI management.